Key Metrics of Roivant Sciences Ltd.
Revenue$32.7M▲ 3.8% YoYFY 2023
Operating income$4.5B▲ 595.9% YoY
Net profit$4.3B▲ 531.0% YoY
Shareholders' equity$6.1B
Market cap$27.1BROIV · $37.45
Competitors10identified
About Roivant Sciences Ltd.
Sectors
Company details
- Listed
- Nasdaq: ROIV
Operational Areas of Roivant Sciences Ltd.
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameRoivant Sciences Ltd.
TickerROIV
ExchangeNasdaq
CountryUnited Kingdom
SEC CIK0001635088
Listed since—
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
ROIV · Nasdaq · SEC CIK 0001635088
Last price · 23 Oct 2026
$37.45
+1.77%
Market cap$27.1B
P/E7.2On FY 2023 diluted EPS
Volume13,451,216
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited Kingdom
ROIV share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Roivant Sciences Ltd.
Competitors10identified
Countries1most in United Kingdom
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Part of Abcam. | abcam.com/en-us | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | abcodia.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | diabetology.co.uk | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | genusplc.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | selectbiosciences.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | vernalis.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | oxitec.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | horizondiscovery.com | — | United Kingdom | |
| Part of Immunocore. | immunocore.com | — | United Kingdom |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.